RE:RE:RE:RE:88!! That is the more interesting question of the day- why Management changed their statements from:
"interim target of 90 patients, an important milestone as the Company’s strategic commercial partner, Baxter (NYSE:BAX), will have the opportunity to view the data as well as provide a second milestone payment to Spectral."
To:
"90 patients (“Interim Enrollment”); at Interim Enrollment, Baxter has the option to make the second milestone payment"
The often repeated "have the opportunity to view the data " has for some reason been removed from the last two releases.. I'd say that's where the story is- and what's behind the change in enrollment.